JP2022508156A5 - - Google Patents
Info
- Publication number
- JP2022508156A5 JP2022508156A5 JP2021528362A JP2021528362A JP2022508156A5 JP 2022508156 A5 JP2022508156 A5 JP 2022508156A5 JP 2021528362 A JP2021528362 A JP 2021528362A JP 2021528362 A JP2021528362 A JP 2021528362A JP 2022508156 A5 JP2022508156 A5 JP 2022508156A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- virus
- host cells
- recombinant oncolytic
- culture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862770577P | 2018-11-21 | 2018-11-21 | |
| US62/770,577 | 2018-11-21 | ||
| PCT/US2019/062643 WO2020106975A1 (en) | 2018-11-21 | 2019-11-21 | Manufacture of virus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022508156A JP2022508156A (ja) | 2022-01-19 |
| JP2022508156A5 true JP2022508156A5 (https=) | 2022-11-22 |
| JP7625519B2 JP7625519B2 (ja) | 2025-02-03 |
Family
ID=70774620
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021528362A Active JP7625519B2 (ja) | 2018-11-21 | 2019-11-21 | ウイルスの製造 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210277363A1 (https=) |
| EP (1) | EP3884044A4 (https=) |
| JP (1) | JP7625519B2 (https=) |
| KR (1) | KR20210093965A (https=) |
| CN (1) | CN113330111A (https=) |
| AU (1) | AU2019384164A1 (https=) |
| CA (1) | CA3120129A1 (https=) |
| WO (1) | WO2020106975A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4222250A1 (en) * | 2020-10-02 | 2023-08-09 | Genelux Corporation | Bioreactor production of virus from adherent cells |
| CN121219392A (zh) * | 2023-05-31 | 2025-12-26 | 康宁股份有限公司 | 用于提高固定床生物反应器的细胞收集效率的方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0981601B1 (en) | 1997-01-31 | 2006-09-06 | Schering Corporation | Methods for cultivating cells and propagating viruses |
| EP2287288B1 (en) * | 2002-07-09 | 2012-11-07 | Baxter International Inc. | Animal protein free media for cultivation of cells |
| US20070207461A1 (en) * | 2004-02-23 | 2007-09-06 | Crucell Holland B.V. | Virus Purification Methods |
| US8541559B2 (en) * | 2006-06-12 | 2013-09-24 | Cytos Biotechnology Ag | Process for producing aggregated oligonucleotides |
| EP2615167A1 (en) * | 2006-09-15 | 2013-07-17 | MedImmune, LLC | Method for eliminating DNA contaminants from viral preparations |
| JP2010526546A (ja) | 2007-05-14 | 2010-08-05 | バヴァリアン・ノルディック・アクティーゼルスカブ | ワクシニアウイルス系及び組換えワクシニアウイルス系ワクチンの精製 |
| US8003363B2 (en) * | 2007-05-14 | 2011-08-23 | Bavarian Nordic A/S | Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines |
| US8785173B2 (en) * | 2008-09-24 | 2014-07-22 | Medimmune, Llc | Methods for purification of viruses |
| EP2739293B1 (en) * | 2011-08-05 | 2020-06-10 | SillaJen Biotherapeutics, Inc. | Methods and compositions for production of vaccina virus |
| US10851350B1 (en) * | 2017-06-27 | 2020-12-01 | Genelux Corporation | Bioreactor production of virus from adherent cells |
-
2019
- 2019-11-21 CA CA3120129A patent/CA3120129A1/en active Pending
- 2019-11-21 WO PCT/US2019/062643 patent/WO2020106975A1/en not_active Ceased
- 2019-11-21 CN CN201980089784.0A patent/CN113330111A/zh active Pending
- 2019-11-21 AU AU2019384164A patent/AU2019384164A1/en active Pending
- 2019-11-21 JP JP2021528362A patent/JP7625519B2/ja active Active
- 2019-11-21 EP EP19887930.6A patent/EP3884044A4/en not_active Withdrawn
- 2019-11-21 KR KR1020217018523A patent/KR20210093965A/ko not_active Ceased
-
2021
- 2021-05-19 US US17/324,756 patent/US20210277363A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5129805B2 (ja) | 細胞培養物から精製水疱性口内炎ウイルスを単離するための精製プロセス | |
| JP2009034115A5 (https=) | ||
| Spann et al. | Genetic recombination during coinfection of two mutants of human respiratory syncytial virus | |
| Brinton | Analysis of extracellular West Nile virus particles produced by cell cultures from genetically resistant and susceptible mice indicates enhanced amplification of defective interfering particles by resistant cultures | |
| JP2004531220A5 (https=) | ||
| JP2019504030A5 (https=) | ||
| JP6385559B2 (ja) | 細胞培養体からのポリオウイルスの精製プロセス | |
| US12305198B2 (en) | Virus purification and formulation process | |
| JP7648642B2 (ja) | ウイルス調製物から宿主細胞ｄｎａを取り除く方法 | |
| JP2025169249A5 (https=) | ||
| Naruse et al. | The polypeptides of mumps virus and their synthesis in infected chick embryo cells | |
| JP2022508156A5 (https=) | ||
| JP2025118611A (ja) | 接着細胞からのウイルスのバイオリアクター生成 | |
| WO2014015816A1 (zh) | 一种去除疫苗中宿主dna的方法 | |
| US20260085294A1 (en) | Process for producing a purified rhabdovirus from cell culture | |
| US20240035002A1 (en) | Method for purifying virus | |
| WO2006038742A1 (ja) | 組み換えウイルスおよびその用途 | |
| Omar et al. | Syncytium Formation and Inhibition in Semliki-Forest-Virus-Infected Aedes Albopictus Cells at Low pH | |
| Mega et al. | Mutagenic analysis of Hazara nairovirus nontranslated regions during single-and multistep growth identifies both attenuating and functionally critical sequences for virus replication | |
| CN113330111A (zh) | 病毒的制造 | |
| CN111662883A (zh) | 一种制备及纯化溶瘤病毒的方法及重组溶瘤弹状病毒 | |
| Pelz et al. | Production of antiviral “OP7 chimera” defective interfering particles free of infectious virus | |
| CN113817689A (zh) | 慢病毒纯化工艺 | |
| KR101581228B1 (ko) | 바이러스의 증식을 위한 ２-단계 온도 프로파일 | |
| CN114272366B (zh) | 一种制备人用乙型脑炎灭活疫苗的方法及疫苗 |